Nabi Biopharmaceuticals - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Nabi Biopharmaceuticals Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Nabi Biopharmaceuticals. The Group's principal activities are to discover, develop, manufacture and market vaccines and antibody based biopharmaceutical products. The Group operates in two segments: Biopharmaceutical products and Antibody products. The Biopharmaceutical products segment includes the production and sale of proprietary biopharmaceutical products, as well as research and development efforts for the biopharmaceutical product line. The Antibody products segment includes the collection and sale of non-specific and specialty antibody products to other biopharmaceutical manufacturers, as well as the production and sale of antibody-body control and diagnostic products and laboratory testing services. The Group operates in the United States, South Korea, Israel and Canada.

Not the Report you are looking for? Click here for more browsing options.

$600/yr | Annual Subscription | Premium Access to more than 150,000 company reports for $600/year**

$59.99/mo | Monthly Subscription | Premium Access to more than 150,000 company reports for $59.99/month**

$39.95 | ALL Reports on this company | Buy all reports for Nabi Biopharma

$24.95 | Single Sales Analysis Report | Buy this Nabi Biopharma Sales Analysis

Set Currency* Argentinian Pesos Australian Dollars Bermudan Dollars Brazilian Reals Canadian Dollars Chilean Pesos Chinese Renmimbi Colombian Pesos Czech Koruni Danish Kroner Dirham Egyptian Pounds Euro Hong Kong Dollars Hungarian Forints Icelandic Kronas Indian Rupees Indonesian Rupiahs Israel Shekels Japanese Yen Jordanian Dinars Korean Won Malaysian Ringgits Mexican Pesos Moroccan Dirhams New Zealand Dollars Norwegian Kroner Pakistan Rupees Peruvian New Sols Philippine Pesos Polish New Zlotys Pounds Sterling Russian Rubles Saudi Riyals Singapore Dollars Slovak Koruni South African Rands Sri Lanka Rupees Swedish Kronor Swiss Francs Taiwanese Dollars Thai Bahts Turkish Liras U.S. Dollars Venezuelan Bolivars Zimbabwe Dollars * If a currency is not selected, the report will be delivered in the local currency of the company ** Premium access limits users to 500 reports per month

Layout and Content of a Typical Report